Pacira BioSciences Inc (PCRX)
26.20
+0.70
(+2.75%)
USD |
NASDAQ |
Apr 26, 12:35
Pacira BioSciences Max Drawdown (5Y): 70.10% for March 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
March 31, 2024 | 70.10% |
February 29, 2024 | 70.10% |
January 31, 2024 | 70.10% |
December 31, 2023 | 70.10% |
November 30, 2023 | 70.10% |
October 31, 2023 | 70.10% |
September 30, 2023 | 70.10% |
August 31, 2023 | 70.10% |
July 31, 2023 | 70.10% |
June 30, 2023 | 70.10% |
May 31, 2023 | 70.10% |
April 30, 2023 | 72.46% |
March 31, 2023 | 74.39% |
February 28, 2023 | 74.39% |
January 31, 2023 | 75.81% |
December 31, 2022 | 76.94% |
November 30, 2022 | 76.94% |
October 31, 2022 | 76.94% |
September 30, 2022 | 76.94% |
August 31, 2022 | 76.94% |
July 31, 2022 | 76.94% |
June 30, 2022 | 76.94% |
May 31, 2022 | 76.94% |
April 30, 2022 | 76.94% |
March 31, 2022 | 76.94% |
Date | Value |
---|---|
February 28, 2022 | 76.94% |
January 31, 2022 | 76.94% |
December 31, 2021 | 76.94% |
November 30, 2021 | 76.94% |
October 31, 2021 | 76.94% |
September 30, 2021 | 76.94% |
August 31, 2021 | 76.94% |
July 31, 2021 | 76.94% |
June 30, 2021 | 76.94% |
May 31, 2021 | 76.94% |
April 30, 2021 | 76.94% |
March 31, 2021 | 76.94% |
February 28, 2021 | 76.94% |
January 31, 2021 | 76.94% |
December 31, 2020 | 76.94% |
November 30, 2020 | 76.94% |
October 31, 2020 | 76.94% |
September 30, 2020 | 76.94% |
August 31, 2020 | 76.94% |
July 31, 2020 | 76.94% |
June 30, 2020 | 76.94% |
May 31, 2020 | 76.94% |
April 30, 2020 | 76.94% |
March 31, 2020 | 76.94% |
February 29, 2020 | 76.94% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
70.10%
Minimum
May 2023
76.94%
Maximum
Apr 2019
75.51%
Average
76.94%
Median
Apr 2019
Max Drawdown (5Y) Benchmarks
Dynavax Technologies Corp | 92.83% |
Arbutus Biopharma Corp | 96.69% |
Chimerix Inc | 97.79% |
Karyopharm Therapeutics Inc | 97.56% |
FibroGen Inc | 99.37% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -17.03 |
Beta (5Y) | 0.7572 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 38.45% |
Historical Sharpe Ratio (5Y) | -0.1858 |
Historical Sortino (5Y) | -0.3127 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.97% |